Dysphagia in dermatomyositis secondary to bladder cancer: Rapid response to combined immunoglobulin and methylprednisolone

Clinical and Experimental Dermatology

Volumn 30, Issue 1, 2005, Pages 93-94

  Hafejee, A ^a   Coulson, I H ^a  

^a BURNLEY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ARTICLE; BLADDER CANCER; CASE REPORT; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; HUMAN; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

AGED; ANTI-INFLAMMATORY AGENTS; CARCINOMA, TRANSITIONAL CELL; DEGLUTITION DISORDERS; DERMATOMYOSITIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; URINARY BLADDER NEOPLASMS;

EID: 13244279480     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01671.x     Document Type: Article

References (4)

1. Mallon E, Osborne G, Dinneen M et al. Dermatomyositis in association with transitional cell carcinoma of the bladder. Clin Exp Dermatol 1999; 24: 94-6.
2. Almog Y, Ben Yehuda A, Ben-Chetrit E. Dermatomyositis associated with the recurrence of transitional carcinoma and Kaposis sarcoma. Clin Exp Rheumatol 1991; 9: 285-8.
3. Marie I, Hachulla E, Levesque H et al. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 1999; 26: 2706-9.
4. Dalakas MC. Controlled studies with high dose intravenous immunoglobulin in the treatment of dermatomysitis, inclusion body myositis and polymyositis. Neurology 1998; 51: S37-45.